Over the years, medical researchers and scientists have continued to make headway in unearthing important information about various ailments. However, patients and caregivers cannot access this information if no efforts are made to make it easily accessible. It is with this in mind that Oncotarget was unveiled. This medical journal provides medical information that goes a long way in helping thousands of individuals from all walks of life to prevent diseases as well as to manage the already existing ones. It allows researchers in various medical sectors contribute to the progress of science in a helpful way.
The Worthy Goals
The much-experienced professionals writing in the Oncotaget journal have worked tirelessly over the years with the main mission of extensively and timely providing proven medical results. Their ultimate goal is to achieve a disease-free world by encouraging the use of clinical and basic science in tackling diseases as well as ensuring that their discoveries make a positive impact on patients and other individuals. They also aim at bringing together different types of biomedical sciences, with a target to remove borders. The Gordon Research Conference sponsors Their research projects. Download output styles at Endnote.com.
Oncotarget medical journal is available both online and in print for special requests. Impact Journal publishes the free to access newsletter on weekly releases. Led by their well-able chief editors Mikhail Blagosklonny, a renowned oncologist, and Andrei V. Gudkov, a cancer researcher and a college professor, Oncotarget is dedicated to preparing well researched and insightfully reviewed materials that combine several disciplines covering all aspects of oncology. Since its inception in 2010, Oncotarget has grown from their initial mission of researching on cancer treatments to engage in other sections that are beyond oncology, such as Immunology & Microbiology, Pathology, Gerotarget/Aging, Neurology, Metabolism, Autophagy, and Cell Death.
Oncotarget has gained popularity among the people for its impeccable performance and generous contributions in the medical field. The relentless efforts of the researchers couldn’t go unnoticed – members of Oncotarget, including Stephen J. Elledge, Michael N. Hall, Alexander Varshavsky, and Bert Vogelstein grabbed the highest award in history, the Breakthrough Prize, in 2013. Follow Oncotarget journal on Twitter.